Trials / Completed
CompletedNCT01089855
Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy Pain
Phase IV Open Non Comparative Trial to Evaluate Efficacy and Safety of Tegretol® in Diabetes Neuropathy Pain.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The trial is designed to evaluate the efficacy and tolerability of carbamazepine in neuropathic pain in diabetic patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carbamazepine |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-07-01
- First posted
- 2010-03-19
- Last updated
- 2017-07-13
Locations
1 site across 1 country: Morocco
Source: ClinicalTrials.gov record NCT01089855. Inclusion in this directory is not an endorsement.